Advestra advises the banking syndicate on the GDR offering and listing on SIX Swiss Exchange of Lepu Medical Technology (Beijing) Co., Ltd.

Lepu Med­ic­al Tech­no­logy (Beijing) Co., Ltd. suc­cess­fully offered and lis­ted its glob­al depos­it­ary receipts (GDRs) on SIX Swiss Exchange. The GDRs were admit­ted to trad­ing and lis­ted on 21 Septem­ber 2022. The A shares of Lepu Med­ic­al Techon­logy are lis­ted on the Shen­zhen Stock Exchange. Lepu Med­ic­al Tech­no­logy raised approx. USD 224 mio. in its GDR offer­ing. Cred­it Suisse, CIT­IC Secur­it­ies and CICC acted as Joint Glob­al Coordin­at­ors and Joint Book­run­ners and China Galaxy Inter­na­tion­al, Huatai Inter­na­tion­al and Haitong Inter­na­tion­al as Joint Book­run­ners in this transaction.

Advestra advised the bank­ing syn­dic­ate on all Swiss law mat­ters related to the trans­ac­tion. The team included Annette Weber, Thomas Reut­ter, Alex­an­der Fisch, Fabi­an Wild, Fabi­an Loretan and Levy Corba (all Cap­it­al Mar­kets) and Céline Mar­tin (Tax).